US 12,433,869 B2
Preventing and treating malaria
Ian Basil Shine, Swampscott, MA (US); and Thomas Adam Shine, Brookline, MA (US)
Assigned to Ian Basil Shine, Swampscott, MA (US); and Thomas Adam Shine, Brookline, MA (US)
Appl. No. 17/605,025
Filed by Ian Basil Shine, Swampscott, MA (US); and Thomas Adam Shine, Brookline, MA (US)
PCT Filed Apr. 21, 2020, PCT No. PCT/US2020/029114
§ 371(c)(1), (2) Date Oct. 20, 2021,
PCT Pub. No. WO2020/219445, PCT Pub. Date Oct. 29, 2020.
Claims priority of provisional application 62/943,689, filed on Dec. 4, 2019.
Claims priority of provisional application 62/836,997, filed on Apr. 22, 2019.
Prior Publication US 2022/0211670 A1, Jul. 7, 2022
Int. Cl. A61K 31/4045 (2006.01); A61K 31/405 (2006.01); A61K 45/06 (2006.01); A61P 33/06 (2006.01); C12N 5/078 (2010.01); G01N 33/50 (2006.01)
CPC A61K 31/4045 (2013.01) [A61K 31/405 (2013.01); A61K 45/06 (2013.01); A61P 33/06 (2018.01); C12N 5/0641 (2013.01); G01N 33/5091 (2013.01); G01N 2333/445 (2013.01)] 20 Claims
 
1. A method of treating or preventing malaria, comprising administering to a subject in need thereof red blood cell (RBC) permeability modulating therapy.